Lex Fridman avatar

Dexa/Lex Fridman

Learn more

FDA Transparency Debate

The discussion centers on the FDA's request to withhold Pfizer data for 75 years, raising concerns about bureaucratic delays and transparency. While one perspective sees this as a failure to inspire trust in science, the other emphasizes the rigorous review process and high caliber of scientists involved. The conversation highlights the tension between regulatory processes and public confidence in health institutions.